Teva Receives Glimepiride Approval; Sanofi Launches Authorized Generic

Drug Industry Daily

Teva Pharmaceutical has received approval from the FDA to launch a generic version of sanofi-aventis’ diabetes treatment Amaryl (glimepiride), but Teva will not have the market to itself, as sanofi-aventis has already moved to launch an authorized generic.

To View This Article:


Subscribe To Drug Industry Daily